Hidrasec: Nervous system disorders: Common: Headache.
Hidrasec Paediatric: Infections and infestations: Uncommon: Tonsillitis.
Skin and subcutaneous tissue disorders: Uncommon: Rash, erythema.
Unknown: Erythema multiforme, tongue oedema, face oedema, lip oedema, eyelid oedema, angioedema, urticaria, erythema nodosum, papular rash, prurigo, pruritus, toxic skin eruption (Hidrasec only).
Hidrasec Paediatric: Paediatric population: In infants or children treated with racecadotril the occurance of tonsilitis has been reported as an uncommon adverse event. There are specific formulations for these age groups.
Hidrasec/Hidrasec Paediatric: Serious skin reactions (including angioedema) have been reported in patients on racecadotril therapy. The incidence of these reactions is unknown but if they occur, racecadotril therapy must be discontinued and appropriate alternative therapy instituted. Patients should be aware not to take racecadotril again in these cases.
View ADR Monitoring Form